nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—Propranolol—migraine	0.413	1	CrCtD
Betaxolol—ADRB2—Timolol—migraine	0.0391	0.182	CbGbCtD
Betaxolol—ADRB1—Timolol—migraine	0.0385	0.18	CbGbCtD
Betaxolol—Acebutolol—Propranolol—migraine	0.0359	0.134	CrCrCtD
Betaxolol—ADRB2—Propranolol—migraine	0.0349	0.163	CbGbCtD
Betaxolol—ADRB1—Propranolol—migraine	0.0344	0.16	CbGbCtD
Betaxolol—Bisoprolol—Propranolol—migraine	0.0335	0.125	CrCrCtD
Betaxolol—Practolol—Propranolol—migraine	0.0296	0.111	CrCrCtD
Betaxolol—Alprenolol—Propranolol—migraine	0.0296	0.111	CrCrCtD
Betaxolol—Metoprolol—Propranolol—migraine	0.0296	0.111	CrCrCtD
Betaxolol—Oxprenolol—Propranolol—migraine	0.0296	0.111	CrCrCtD
Betaxolol—Atenolol—Propranolol—migraine	0.028	0.105	CrCrCtD
Betaxolol—Esmolol—Propranolol—migraine	0.0266	0.0994	CrCrCtD
Betaxolol—Pindolol—Propranolol—migraine	0.0253	0.0946	CrCrCtD
Betaxolol—CYP1A2—Propranolol—migraine	0.0106	0.0495	CbGbCtD
Betaxolol—CYP2D6—Timolol—migraine	0.00982	0.0458	CbGbCtD
Betaxolol—CYP1A2—Amitriptyline—migraine	0.00918	0.0428	CbGbCtD
Betaxolol—CYP2D6—Propranolol—migraine	0.00875	0.0408	CbGbCtD
Betaxolol—CYP1A2—Valproic Acid—migraine	0.00837	0.039	CbGbCtD
Betaxolol—CYP2D6—Amitriptyline—migraine	0.00757	0.0353	CbGbCtD
Betaxolol—CYP1A2—Verapamil—migraine	0.00729	0.034	CbGbCtD
Betaxolol—CYP2D6—Verapamil—migraine	0.006	0.028	CbGbCtD
Betaxolol—ADRB1—Endothelin Pathways—RAMP1—migraine	0.000738	0.0395	CbGpPWpGaD
Betaxolol—ADRB1—Endothelin Pathways—CALCRL—migraine	0.000738	0.0395	CbGpPWpGaD
Betaxolol—ADRB1—Monoamine GPCRs—HTR1D—migraine	0.000536	0.0287	CbGpPWpGaD
Betaxolol—ADRB2—Monoamine GPCRs—HTR1D—migraine	0.000524	0.0281	CbGpPWpGaD
Betaxolol—ADRB1—Monoamine GPCRs—HTR2B—migraine	0.000498	0.0267	CbGpPWpGaD
Betaxolol—ADRB2—Monoamine GPCRs—HTR2B—migraine	0.000488	0.0261	CbGpPWpGaD
Betaxolol—ADRB1—Amine ligand-binding receptors—HTR1D—migraine	0.000451	0.0241	CbGpPWpGaD
Betaxolol—ADRB2—Amine ligand-binding receptors—HTR1D—migraine	0.000441	0.0236	CbGpPWpGaD
Betaxolol—ADRB1—Amine ligand-binding receptors—HTR2B—migraine	0.000419	0.0224	CbGpPWpGaD
Betaxolol—ADRB2—Amine ligand-binding receptors—HTR2B—migraine	0.00041	0.0219	CbGpPWpGaD
Betaxolol—Pindolol—HTR1B—migraine	0.000327	0.271	CrCbGaD
Betaxolol—ADRB1—Monoamine GPCRs—HTR1B—migraine	0.000325	0.0174	CbGpPWpGaD
Betaxolol—ADRB2—Monoamine GPCRs—HTR1B—migraine	0.000318	0.017	CbGpPWpGaD
Betaxolol—ADRB1—Monoamine GPCRs—HTR1A—migraine	0.000313	0.0167	CbGpPWpGaD
Betaxolol—ADRB2—Monoamine GPCRs—HTR1A—migraine	0.000306	0.0164	CbGpPWpGaD
Betaxolol—ADRB1—Monoamine GPCRs—HTR2C—migraine	0.000302	0.0162	CbGpPWpGaD
Betaxolol—Alprenolol—HTR1A—migraine	0.000301	0.249	CrCbGaD
Betaxolol—ADRB2—Monoamine GPCRs—HTR2C—migraine	0.000295	0.0158	CbGpPWpGaD
Betaxolol—ADRB1—Endothelin Pathways—EDNRA—migraine	0.000294	0.0157	CbGpPWpGaD
Betaxolol—ADRB1—Endothelin Pathways—CALCA—migraine	0.000283	0.0151	CbGpPWpGaD
Betaxolol—ADRB1—Amine ligand-binding receptors—HTR1B—migraine	0.000273	0.0146	CbGpPWpGaD
Betaxolol—ADRB2—Amine ligand-binding receptors—HTR1B—migraine	0.000267	0.0143	CbGpPWpGaD
Betaxolol—ADRB1—Monoamine GPCRs—HTR7—migraine	0.000265	0.0142	CbGpPWpGaD
Betaxolol—ADRB1—Amine ligand-binding receptors—HTR1A—migraine	0.000263	0.0141	CbGpPWpGaD
Betaxolol—Pindolol—HTR1A—migraine	0.000259	0.215	CrCbGaD
Betaxolol—ADRB2—Monoamine GPCRs—HTR7—migraine	0.000259	0.0138	CbGpPWpGaD
Betaxolol—ADRB2—Amine ligand-binding receptors—HTR1A—migraine	0.000257	0.0138	CbGpPWpGaD
Betaxolol—ADRB1—G alpha (s) signalling events—CALCRL—migraine	0.000256	0.0137	CbGpPWpGaD
Betaxolol—ADRB1—G alpha (s) signalling events—RAMP1—migraine	0.000256	0.0137	CbGpPWpGaD
Betaxolol—ADRB1—Amine ligand-binding receptors—HTR2C—migraine	0.000254	0.0136	CbGpPWpGaD
Betaxolol—ADRB2—G alpha (s) signalling events—RAMP1—migraine	0.00025	0.0134	CbGpPWpGaD
Betaxolol—ADRB2—G alpha (s) signalling events—CALCRL—migraine	0.00025	0.0134	CbGpPWpGaD
Betaxolol—ADRB2—Amine ligand-binding receptors—HTR2C—migraine	0.000248	0.0133	CbGpPWpGaD
Betaxolol—ADRB1—Amine ligand-binding receptors—HTR7—migraine	0.000222	0.0119	CbGpPWpGaD
Betaxolol—ADRB2—Amine ligand-binding receptors—HTR7—migraine	0.000217	0.0116	CbGpPWpGaD
Betaxolol—ADRB1—Monoamine GPCRs—HTR2A—migraine	0.000185	0.00991	CbGpPWpGaD
Betaxolol—ADRB2—Monoamine GPCRs—HTR2A—migraine	0.000181	0.0097	CbGpPWpGaD
Betaxolol—Propranolol—HTR1B—migraine	0.000179	0.148	CrCbGaD
Betaxolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000167	0.00896	CbGpPWpGaD
Betaxolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000164	0.00876	CbGpPWpGaD
Betaxolol—ADRB1—Amine ligand-binding receptors—HTR2A—migraine	0.000156	0.00833	CbGpPWpGaD
Betaxolol—ADRB2—Amine ligand-binding receptors—HTR2A—migraine	0.000152	0.00815	CbGpPWpGaD
Betaxolol—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	0.000144	0.00769	CbGpPWpGaD
Betaxolol—Propranolol—HTR1A—migraine	0.000141	0.117	CrCbGaD
Betaxolol—ADRB2—GPCRs, Other—EDNRA—migraine	0.000128	0.00683	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Other—HTR7—migraine	0.000115	0.00615	CbGpPWpGaD
Betaxolol—ADRB1—G alpha (s) signalling events—NPS—migraine	0.000107	0.00571	CbGpPWpGaD
Betaxolol—ADRB2—G alpha (s) signalling events—NPS—migraine	0.000104	0.00559	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000103	0.00554	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000101	0.00542	CbGpPWpGaD
Betaxolol—ADRB1—G alpha (s) signalling events—CALCA—migraine	9.81e-05	0.00525	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	9.62e-05	0.00515	CbGpPWpGaD
Betaxolol—ADRB2—G alpha (s) signalling events—CALCA—migraine	9.59e-05	0.00513	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	9.41e-05	0.00503	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—RAMP1—migraine	9.29e-05	0.00497	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—CALCRL—migraine	9.29e-05	0.00497	CbGpPWpGaD
Betaxolol—ADRB1—G alpha (s) signalling events—HTR7—migraine	9.17e-05	0.00491	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—CALCRL—migraine	9.09e-05	0.00486	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—RAMP1—migraine	9.09e-05	0.00486	CbGpPWpGaD
Betaxolol—ADRB2—G alpha (s) signalling events—HTR7—migraine	8.97e-05	0.0048	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	8.86e-05	0.00474	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	8.67e-05	0.00464	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	8.24e-05	0.00441	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	8.06e-05	0.00431	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Other—HTR2A—migraine	8.05e-05	0.00431	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—HTR1D—migraine	6.75e-05	0.00361	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—HTR1D—migraine	6.6e-05	0.00353	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—HTR2B—migraine	6.28e-05	0.00336	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	6.27e-05	0.00335	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—HTR2B—migraine	6.14e-05	0.00328	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	6.13e-05	0.00328	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	6.03e-05	0.00323	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	5.9e-05	0.00316	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	5.83e-05	0.00312	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	5.7e-05	0.00305	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	5.67e-05	0.00303	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	5.55e-05	0.00297	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	5.37e-05	0.00287	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	5.25e-05	0.00281	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—RAMP1—migraine	5.25e-05	0.00281	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—CALCRL—migraine	5.25e-05	0.00281	CbGpPWpGaD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	5.23e-05	0.0028	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	5.17e-05	0.00277	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—RAMP1—migraine	5.14e-05	0.00275	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—CALCRL—migraine	5.14e-05	0.00275	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	5.1e-05	0.00273	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	5.09e-05	0.00272	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	5.09e-05	0.00272	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	5.06e-05	0.00271	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	4.99e-05	0.00267	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	4.99e-05	0.00267	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	4.98e-05	0.00266	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	4.98e-05	0.00266	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	4.88e-05	0.00261	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	4.86e-05	0.0026	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CALCRL—migraine	4.77e-05	0.00255	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—RAMP1—migraine	4.77e-05	0.00255	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	4.75e-05	0.00254	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—RAMP1—migraine	4.66e-05	0.0025	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CALCRL—migraine	4.66e-05	0.0025	CbGpPWpGaD
Betaxolol—Eye disorder—Gabapentin—migraine	4.53e-05	0.000534	CcSEcCtD
Betaxolol—Depression—Topiramate—migraine	4.53e-05	0.000534	CcSEcCtD
Betaxolol—Tinnitus—Gabapentin—migraine	4.52e-05	0.000533	CcSEcCtD
Betaxolol—Cardiac disorder—Gabapentin—migraine	4.5e-05	0.00053	CcSEcCtD
Betaxolol—Palpitations—Valproic Acid—migraine	4.49e-05	0.00053	CcSEcCtD
Betaxolol—Neuropathy peripheral—Topiramate—migraine	4.45e-05	0.000525	CcSEcCtD
Betaxolol—Tension—Timolol—migraine	4.44e-05	0.000524	CcSEcCtD
Betaxolol—Cough—Valproic Acid—migraine	4.44e-05	0.000524	CcSEcCtD
Betaxolol—Dysgeusia—Timolol—migraine	4.43e-05	0.000523	CcSEcCtD
Betaxolol—Stomatitis—Topiramate—migraine	4.42e-05	0.000522	CcSEcCtD
Betaxolol—Conjunctivitis—Topiramate—migraine	4.41e-05	0.00052	CcSEcCtD
Betaxolol—Nervousness—Timolol—migraine	4.4e-05	0.000519	CcSEcCtD
Betaxolol—Immune system disorder—Gabapentin—migraine	4.38e-05	0.000516	CcSEcCtD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.37e-05	0.00234	CbGpPWpGaD
Betaxolol—Mediastinal disorder—Gabapentin—migraine	4.37e-05	0.000515	CcSEcCtD
Betaxolol—Diarrhoea—Propranolol—migraine	4.35e-05	0.000514	CcSEcCtD
Betaxolol—Chills—Gabapentin—migraine	4.35e-05	0.000513	CcSEcCtD
Betaxolol—Arthralgia—Valproic Acid—migraine	4.33e-05	0.000511	CcSEcCtD
Betaxolol—Myalgia—Valproic Acid—migraine	4.33e-05	0.000511	CcSEcCtD
Betaxolol—Chest pain—Valproic Acid—migraine	4.33e-05	0.000511	CcSEcCtD
Betaxolol—Anxiety—Valproic Acid—migraine	4.32e-05	0.000509	CcSEcCtD
Betaxolol—Hypersensitivity—Verapamil—migraine	4.31e-05	0.000509	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	4.3e-05	0.000507	CcSEcCtD
Betaxolol—Epistaxis—Topiramate—migraine	4.28e-05	0.000505	CcSEcCtD
Betaxolol—Alopecia—Gabapentin—migraine	4.28e-05	0.000505	CcSEcCtD
Betaxolol—Discomfort—Valproic Acid—migraine	4.28e-05	0.000505	CcSEcCtD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.28e-05	0.00229	CbGpPWpGaD
Betaxolol—Vision blurred—Timolol—migraine	4.27e-05	0.000503	CcSEcCtD
Betaxolol—Sinusitis—Topiramate—migraine	4.26e-05	0.000502	CcSEcCtD
Betaxolol—Mental disorder—Gabapentin—migraine	4.24e-05	0.000501	CcSEcCtD
Betaxolol—Agranulocytosis—Topiramate—migraine	4.24e-05	0.0005	CcSEcCtD
Betaxolol—Dry mouth—Valproic Acid—migraine	4.24e-05	0.0005	CcSEcCtD
Betaxolol—Malnutrition—Gabapentin—migraine	4.22e-05	0.000497	CcSEcCtD
Betaxolol—Erythema—Gabapentin—migraine	4.22e-05	0.000497	CcSEcCtD
Betaxolol—Dizziness—Propranolol—migraine	4.21e-05	0.000496	CcSEcCtD
Betaxolol—Asthenia—Verapamil—migraine	4.2e-05	0.000495	CcSEcCtD
Betaxolol—Confusional state—Valproic Acid—migraine	4.19e-05	0.000494	CcSEcCtD
Betaxolol—Oedema—Valproic Acid—migraine	4.15e-05	0.00049	CcSEcCtD
Betaxolol—Bradycardia—Topiramate—migraine	4.15e-05	0.000489	CcSEcCtD
Betaxolol—Pruritus—Verapamil—migraine	4.14e-05	0.000489	CcSEcCtD
Betaxolol—Tension—Gabapentin—migraine	4.14e-05	0.000488	CcSEcCtD
Betaxolol—Dysgeusia—Gabapentin—migraine	4.13e-05	0.000487	CcSEcCtD
Betaxolol—Infection—Valproic Acid—migraine	4.12e-05	0.000486	CcSEcCtD
Betaxolol—Nervousness—Gabapentin—migraine	4.1e-05	0.000483	CcSEcCtD
Betaxolol—ADRB1—GPCR ligand binding—HTR1B—migraine	4.09e-05	0.00219	CbGpPWpGaD
Betaxolol—Rhinitis—Topiramate—migraine	4.09e-05	0.000482	CcSEcCtD
Betaxolol—Nervous system disorder—Valproic Acid—migraine	4.07e-05	0.00048	CcSEcCtD
Betaxolol—Vertigo—Timolol—migraine	4.07e-05	0.00048	CcSEcCtD
Betaxolol—Thrombocytopenia—Valproic Acid—migraine	4.06e-05	0.000479	CcSEcCtD
Betaxolol—Syncope—Timolol—migraine	4.06e-05	0.000479	CcSEcCtD
Betaxolol—Hypoaesthesia—Topiramate—migraine	4.05e-05	0.000478	CcSEcCtD
Betaxolol—Hallucination—Topiramate—migraine	4.05e-05	0.000478	CcSEcCtD
Betaxolol—Muscle spasms—Gabapentin—migraine	4.05e-05	0.000478	CcSEcCtD
Betaxolol—Tachycardia—Valproic Acid—migraine	4.05e-05	0.000478	CcSEcCtD
Betaxolol—Vomiting—Propranolol—migraine	4.05e-05	0.000477	CcSEcCtD
Betaxolol—Pharyngitis—Topiramate—migraine	4.04e-05	0.000477	CcSEcCtD
Betaxolol—Skin disorder—Valproic Acid—migraine	4.03e-05	0.000476	CcSEcCtD
Betaxolol—Hyperhidrosis—Valproic Acid—migraine	4.01e-05	0.000473	CcSEcCtD
Betaxolol—Rash—Propranolol—migraine	4.01e-05	0.000473	CcSEcCtD
Betaxolol—Dermatitis—Propranolol—migraine	4.01e-05	0.000473	CcSEcCtD
Betaxolol—Diarrhoea—Verapamil—migraine	4.01e-05	0.000473	CcSEcCtD
Betaxolol—Palpitations—Timolol—migraine	4e-05	0.000472	CcSEcCtD
Betaxolol—ADRB2—GPCR ligand binding—HTR1B—migraine	4e-05	0.00214	CbGpPWpGaD
Betaxolol—Loss of consciousness—Timolol—migraine	3.98e-05	0.000469	CcSEcCtD
Betaxolol—Vision blurred—Gabapentin—migraine	3.97e-05	0.000469	CcSEcCtD
Betaxolol—Anorexia—Valproic Acid—migraine	3.96e-05	0.000467	CcSEcCtD
Betaxolol—Cough—Timolol—migraine	3.95e-05	0.000466	CcSEcCtD
Betaxolol—Tremor—Gabapentin—migraine	3.95e-05	0.000466	CcSEcCtD
Betaxolol—ADRB1—GPCR ligand binding—HTR1A—migraine	3.94e-05	0.00211	CbGpPWpGaD
Betaxolol—Visual impairment—Topiramate—migraine	3.93e-05	0.000463	CcSEcCtD
Betaxolol—Ill-defined disorder—Gabapentin—migraine	3.91e-05	0.000461	CcSEcCtD
Betaxolol—Anaemia—Gabapentin—migraine	3.9e-05	0.00046	CcSEcCtD
Betaxolol—Hypotension—Valproic Acid—migraine	3.88e-05	0.000458	CcSEcCtD
Betaxolol—ADRB1—GPCR ligand binding—TAC1—migraine	3.88e-05	0.00207	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—NPS—migraine	3.88e-05	0.00207	CbGpPWpGaD
Betaxolol—Dizziness—Verapamil—migraine	3.87e-05	0.000457	CcSEcCtD
Betaxolol—Arthralgia—Timolol—migraine	3.85e-05	0.000455	CcSEcCtD
Betaxolol—Myalgia—Timolol—migraine	3.85e-05	0.000455	CcSEcCtD
Betaxolol—Chest pain—Timolol—migraine	3.85e-05	0.000455	CcSEcCtD
Betaxolol—ADRB2—GPCR ligand binding—HTR1A—migraine	3.85e-05	0.00206	CbGpPWpGaD
Betaxolol—Anxiety—Timolol—migraine	3.84e-05	0.000453	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	3.83e-05	0.000452	CcSEcCtD
Betaxolol—ADRB1—GPCR downstream signaling—HTR1D—migraine	3.81e-05	0.00204	CbGpPWpGaD
Betaxolol—Discomfort—Timolol—migraine	3.81e-05	0.000449	CcSEcCtD
Betaxolol—Eye disorder—Topiramate—migraine	3.81e-05	0.000449	CcSEcCtD
Betaxolol—Malaise—Gabapentin—migraine	3.8e-05	0.000449	CcSEcCtD
Betaxolol—ADRB1—GPCR ligand binding—HTR2C—migraine	3.8e-05	0.00203	CbGpPWpGaD
Betaxolol—Tinnitus—Topiramate—migraine	3.8e-05	0.000448	CcSEcCtD
Betaxolol—ADRB2—GPCR ligand binding—TAC1—migraine	3.79e-05	0.00203	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—NPS—migraine	3.79e-05	0.00203	CbGpPWpGaD
Betaxolol—Vertigo—Gabapentin—migraine	3.79e-05	0.000447	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Valproic Acid—migraine	3.78e-05	0.000446	CcSEcCtD
Betaxolol—Cardiac disorder—Topiramate—migraine	3.78e-05	0.000446	CcSEcCtD
Betaxolol—Flushing—Topiramate—migraine	3.78e-05	0.000446	CcSEcCtD
Betaxolol—Syncope—Gabapentin—migraine	3.78e-05	0.000446	CcSEcCtD
Betaxolol—Nausea—Propranolol—migraine	3.78e-05	0.000446	CcSEcCtD
Betaxolol—Dry mouth—Timolol—migraine	3.77e-05	0.000445	CcSEcCtD
Betaxolol—Insomnia—Valproic Acid—migraine	3.75e-05	0.000443	CcSEcCtD
Betaxolol—ADRB2—GPCR downstream signaling—HTR1D—migraine	3.73e-05	0.002	CbGpPWpGaD
Betaxolol—Paraesthesia—Valproic Acid—migraine	3.73e-05	0.00044	CcSEcCtD
Betaxolol—Palpitations—Gabapentin—migraine	3.73e-05	0.00044	CcSEcCtD
Betaxolol—Confusional state—Timolol—migraine	3.73e-05	0.00044	CcSEcCtD
Betaxolol—Vomiting—Verapamil—migraine	3.72e-05	0.000439	CcSEcCtD
Betaxolol—ADRB2—GPCR ligand binding—HTR2C—migraine	3.72e-05	0.00199	CbGpPWpGaD
Betaxolol—Loss of consciousness—Gabapentin—migraine	3.71e-05	0.000437	CcSEcCtD
Betaxolol—Dyspnoea—Valproic Acid—migraine	3.7e-05	0.000437	CcSEcCtD
Betaxolol—ADRB1—GPCR ligand binding—EDNRA—migraine	3.7e-05	0.00198	CbGpPWpGaD
Betaxolol—Angiopathy—Topiramate—migraine	3.7e-05	0.000436	CcSEcCtD
Betaxolol—Oedema—Timolol—migraine	3.7e-05	0.000436	CcSEcCtD
Betaxolol—Rash—Verapamil—migraine	3.69e-05	0.000435	CcSEcCtD
Betaxolol—Dermatitis—Verapamil—migraine	3.69e-05	0.000435	CcSEcCtD
Betaxolol—Immune system disorder—Topiramate—migraine	3.68e-05	0.000434	CcSEcCtD
Betaxolol—Cough—Gabapentin—migraine	3.68e-05	0.000434	CcSEcCtD
Betaxolol—Mediastinal disorder—Topiramate—migraine	3.67e-05	0.000433	CcSEcCtD
Betaxolol—Infection—Timolol—migraine	3.67e-05	0.000433	CcSEcCtD
Betaxolol—Headache—Verapamil—migraine	3.67e-05	0.000433	CcSEcCtD
Betaxolol—Chills—Topiramate—migraine	3.66e-05	0.000431	CcSEcCtD
Betaxolol—Dyspepsia—Valproic Acid—migraine	3.65e-05	0.000431	CcSEcCtD
Betaxolol—Shock—Timolol—migraine	3.64e-05	0.000429	CcSEcCtD
Betaxolol—Nervous system disorder—Timolol—migraine	3.62e-05	0.000427	CcSEcCtD
Betaxolol—ADRB2—GPCR ligand binding—EDNRA—migraine	3.62e-05	0.00194	CbGpPWpGaD
Betaxolol—Decreased appetite—Valproic Acid—migraine	3.61e-05	0.000426	CcSEcCtD
Betaxolol—Alopecia—Topiramate—migraine	3.6e-05	0.000425	CcSEcCtD
Betaxolol—Arthralgia—Gabapentin—migraine	3.59e-05	0.000423	CcSEcCtD
Betaxolol—Chest pain—Gabapentin—migraine	3.59e-05	0.000423	CcSEcCtD
Betaxolol—Myalgia—Gabapentin—migraine	3.59e-05	0.000423	CcSEcCtD
Betaxolol—Skin disorder—Timolol—migraine	3.59e-05	0.000423	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Valproic Acid—migraine	3.58e-05	0.000423	CcSEcCtD
Betaxolol—Fatigue—Valproic Acid—migraine	3.58e-05	0.000422	CcSEcCtD
Betaxolol—Anxiety—Gabapentin—migraine	3.58e-05	0.000422	CcSEcCtD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.58e-05	0.00191	CbGpPWpGaD
Betaxolol—Hyperhidrosis—Timolol—migraine	3.57e-05	0.000421	CcSEcCtD
Betaxolol—Mental disorder—Topiramate—migraine	3.57e-05	0.000421	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	3.57e-05	0.000421	CcSEcCtD
Betaxolol—ADRB1—GPCR ligand binding—CALCA—migraine	3.56e-05	0.0019	CbGpPWpGaD
Betaxolol—Pain—Valproic Acid—migraine	3.55e-05	0.000419	CcSEcCtD
Betaxolol—Constipation—Valproic Acid—migraine	3.55e-05	0.000419	CcSEcCtD
Betaxolol—Erythema—Topiramate—migraine	3.55e-05	0.000418	CcSEcCtD
Betaxolol—Malnutrition—Topiramate—migraine	3.55e-05	0.000418	CcSEcCtD
Betaxolol—Discomfort—Gabapentin—migraine	3.55e-05	0.000418	CcSEcCtD
Betaxolol—ADRB1—GPCR downstream signaling—HTR2B—migraine	3.55e-05	0.0019	CbGpPWpGaD
Betaxolol—Anorexia—Timolol—migraine	3.52e-05	0.000415	CcSEcCtD
Betaxolol—Dry mouth—Gabapentin—migraine	3.51e-05	0.000414	CcSEcCtD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.5e-05	0.00187	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—CALCA—migraine	3.48e-05	0.00186	CbGpPWpGaD
Betaxolol—Tension—Topiramate—migraine	3.48e-05	0.000411	CcSEcCtD
Betaxolol—Nausea—Verapamil—migraine	3.48e-05	0.00041	CcSEcCtD
Betaxolol—Dysgeusia—Topiramate—migraine	3.47e-05	0.00041	CcSEcCtD
Betaxolol—Confusional state—Gabapentin—migraine	3.47e-05	0.000409	CcSEcCtD
Betaxolol—ADRB2—GPCR downstream signaling—HTR2B—migraine	3.47e-05	0.00186	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HTR1D—migraine	3.46e-05	0.00185	CbGpPWpGaD
Betaxolol—Hypotension—Timolol—migraine	3.45e-05	0.000407	CcSEcCtD
Betaxolol—Nervousness—Topiramate—migraine	3.45e-05	0.000406	CcSEcCtD
Betaxolol—Oedema—Gabapentin—migraine	3.44e-05	0.000406	CcSEcCtD
Betaxolol—Feeling abnormal—Valproic Acid—migraine	3.42e-05	0.000403	CcSEcCtD
Betaxolol—Infection—Gabapentin—migraine	3.42e-05	0.000403	CcSEcCtD
Betaxolol—Muscle spasms—Topiramate—migraine	3.41e-05	0.000402	CcSEcCtD
Betaxolol—ADRB2—Signaling by GPCR—HTR1D—migraine	3.39e-05	0.00181	CbGpPWpGaD
Betaxolol—Shock—Gabapentin—migraine	3.39e-05	0.000399	CcSEcCtD
Betaxolol—Nervous system disorder—Gabapentin—migraine	3.37e-05	0.000398	CcSEcCtD
Betaxolol—Thrombocytopenia—Gabapentin—migraine	3.37e-05	0.000397	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Timolol—migraine	3.37e-05	0.000397	CcSEcCtD
Betaxolol—Tachycardia—Gabapentin—migraine	3.36e-05	0.000396	CcSEcCtD
Betaxolol—Vision blurred—Topiramate—migraine	3.34e-05	0.000394	CcSEcCtD
Betaxolol—Skin disorder—Gabapentin—migraine	3.34e-05	0.000394	CcSEcCtD
Betaxolol—Insomnia—Timolol—migraine	3.34e-05	0.000394	CcSEcCtD
Betaxolol—ADRB1—GPCR ligand binding—HTR7—migraine	3.33e-05	0.00178	CbGpPWpGaD
Betaxolol—Hyperhidrosis—Gabapentin—migraine	3.33e-05	0.000392	CcSEcCtD
Betaxolol—Tremor—Topiramate—migraine	3.32e-05	0.000392	CcSEcCtD
Betaxolol—Paraesthesia—Timolol—migraine	3.32e-05	0.000391	CcSEcCtD
Betaxolol—Urticaria—Valproic Acid—migraine	3.3e-05	0.000389	CcSEcCtD
Betaxolol—Dyspnoea—Timolol—migraine	3.29e-05	0.000389	CcSEcCtD
Betaxolol—Ill-defined disorder—Topiramate—migraine	3.29e-05	0.000388	CcSEcCtD
Betaxolol—Body temperature increased—Valproic Acid—migraine	3.28e-05	0.000387	CcSEcCtD
Betaxolol—Anorexia—Gabapentin—migraine	3.28e-05	0.000387	CcSEcCtD
Betaxolol—Anaemia—Topiramate—migraine	3.28e-05	0.000387	CcSEcCtD
Betaxolol—ADRB2—GPCR ligand binding—HTR7—migraine	3.26e-05	0.00174	CbGpPWpGaD
Betaxolol—Dyspepsia—Timolol—migraine	3.25e-05	0.000384	CcSEcCtD
Betaxolol—ADRB1—Signaling by GPCR—HTR2B—migraine	3.22e-05	0.00172	CbGpPWpGaD
Betaxolol—Hypotension—Gabapentin—migraine	3.22e-05	0.000379	CcSEcCtD
Betaxolol—Decreased appetite—Timolol—migraine	3.21e-05	0.000379	CcSEcCtD
Betaxolol—Malaise—Topiramate—migraine	3.2e-05	0.000377	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Timolol—migraine	3.19e-05	0.000376	CcSEcCtD
Betaxolol—Vertigo—Topiramate—migraine	3.19e-05	0.000376	CcSEcCtD
Betaxolol—Fatigue—Timolol—migraine	3.19e-05	0.000376	CcSEcCtD
Betaxolol—Syncope—Topiramate—migraine	3.18e-05	0.000375	CcSEcCtD
Betaxolol—Pain—Timolol—migraine	3.16e-05	0.000373	CcSEcCtD
Betaxolol—ADRB2—Signaling by GPCR—HTR2B—migraine	3.15e-05	0.00169	CbGpPWpGaD
Betaxolol—Musculoskeletal discomfort—Gabapentin—migraine	3.14e-05	0.00037	CcSEcCtD
Betaxolol—Palpitations—Topiramate—migraine	3.14e-05	0.00037	CcSEcCtD
Betaxolol—Loss of consciousness—Topiramate—migraine	3.12e-05	0.000368	CcSEcCtD
Betaxolol—Insomnia—Gabapentin—migraine	3.11e-05	0.000367	CcSEcCtD
Betaxolol—Cough—Topiramate—migraine	3.1e-05	0.000365	CcSEcCtD
Betaxolol—Paraesthesia—Gabapentin—migraine	3.09e-05	0.000364	CcSEcCtD
Betaxolol—Dyspnoea—Gabapentin—migraine	3.07e-05	0.000362	CcSEcCtD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.06e-05	0.00164	CbGpPWpGaD
Betaxolol—Hypersensitivity—Valproic Acid—migraine	3.06e-05	0.000361	CcSEcCtD
Betaxolol—Feeling abnormal—Timolol—migraine	3.05e-05	0.000359	CcSEcCtD
Betaxolol—Dyspepsia—Gabapentin—migraine	3.03e-05	0.000357	CcSEcCtD
Betaxolol—Myalgia—Topiramate—migraine	3.02e-05	0.000356	CcSEcCtD
Betaxolol—Arthralgia—Topiramate—migraine	3.02e-05	0.000356	CcSEcCtD
Betaxolol—Chest pain—Topiramate—migraine	3.02e-05	0.000356	CcSEcCtD
Betaxolol—Anxiety—Topiramate—migraine	3.01e-05	0.000355	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	3e-05	0.000354	CcSEcCtD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3e-05	0.0016	CbGpPWpGaD
Betaxolol—Decreased appetite—Gabapentin—migraine	2.99e-05	0.000353	CcSEcCtD
Betaxolol—Discomfort—Topiramate—migraine	2.98e-05	0.000352	CcSEcCtD
Betaxolol—Asthenia—Valproic Acid—migraine	2.98e-05	0.000351	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Gabapentin—migraine	2.97e-05	0.00035	CcSEcCtD
Betaxolol—Fatigue—Gabapentin—migraine	2.97e-05	0.00035	CcSEcCtD
Betaxolol—Dry mouth—Topiramate—migraine	2.95e-05	0.000348	CcSEcCtD
Betaxolol—Pain—Gabapentin—migraine	2.94e-05	0.000347	CcSEcCtD
Betaxolol—Constipation—Gabapentin—migraine	2.94e-05	0.000347	CcSEcCtD
Betaxolol—Pruritus—Valproic Acid—migraine	2.94e-05	0.000346	CcSEcCtD
Betaxolol—Urticaria—Timolol—migraine	2.94e-05	0.000346	CcSEcCtD
Betaxolol—Body temperature increased—Timolol—migraine	2.92e-05	0.000345	CcSEcCtD
Betaxolol—Confusional state—Topiramate—migraine	2.92e-05	0.000344	CcSEcCtD
Betaxolol—Oedema—Topiramate—migraine	2.9e-05	0.000342	CcSEcCtD
Betaxolol—Infection—Topiramate—migraine	2.88e-05	0.000339	CcSEcCtD
Betaxolol—Shock—Topiramate—migraine	2.85e-05	0.000336	CcSEcCtD
Betaxolol—Diarrhoea—Valproic Acid—migraine	2.84e-05	0.000335	CcSEcCtD
Betaxolol—Nervous system disorder—Topiramate—migraine	2.84e-05	0.000335	CcSEcCtD
Betaxolol—Feeling abnormal—Gabapentin—migraine	2.84e-05	0.000334	CcSEcCtD
Betaxolol—Thrombocytopenia—Topiramate—migraine	2.83e-05	0.000334	CcSEcCtD
Betaxolol—Tachycardia—Topiramate—migraine	2.83e-05	0.000333	CcSEcCtD
Betaxolol—ADRB1—Signaling Pathways—CALCRL—migraine	2.82e-05	0.00151	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RAMP1—migraine	2.82e-05	0.00151	CbGpPWpGaD
Betaxolol—Skin disorder—Topiramate—migraine	2.81e-05	0.000332	CcSEcCtD
Betaxolol—Hyperhidrosis—Topiramate—migraine	2.8e-05	0.00033	CcSEcCtD
Betaxolol—Anorexia—Topiramate—migraine	2.76e-05	0.000326	CcSEcCtD
Betaxolol—ADRB2—Signaling Pathways—CALCRL—migraine	2.76e-05	0.00147	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RAMP1—migraine	2.76e-05	0.00147	CbGpPWpGaD
Betaxolol—Dizziness—Valproic Acid—migraine	2.75e-05	0.000324	CcSEcCtD
Betaxolol—Urticaria—Gabapentin—migraine	2.73e-05	0.000322	CcSEcCtD
Betaxolol—Hypersensitivity—Timolol—migraine	2.72e-05	0.000321	CcSEcCtD
Betaxolol—Body temperature increased—Gabapentin—migraine	2.72e-05	0.000321	CcSEcCtD
Betaxolol—Hypotension—Topiramate—migraine	2.71e-05	0.000319	CcSEcCtD
Betaxolol—Asthenia—Timolol—migraine	2.65e-05	0.000313	CcSEcCtD
Betaxolol—Vomiting—Valproic Acid—migraine	2.64e-05	0.000311	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Topiramate—migraine	2.64e-05	0.000311	CcSEcCtD
Betaxolol—Insomnia—Topiramate—migraine	2.62e-05	0.000309	CcSEcCtD
Betaxolol—Rash—Valproic Acid—migraine	2.62e-05	0.000309	CcSEcCtD
Betaxolol—Dermatitis—Valproic Acid—migraine	2.62e-05	0.000308	CcSEcCtD
Betaxolol—Pruritus—Timolol—migraine	2.61e-05	0.000308	CcSEcCtD
Betaxolol—Headache—Valproic Acid—migraine	2.6e-05	0.000307	CcSEcCtD
Betaxolol—Paraesthesia—Topiramate—migraine	2.6e-05	0.000307	CcSEcCtD
Betaxolol—Dyspnoea—Topiramate—migraine	2.58e-05	0.000304	CcSEcCtD
Betaxolol—Dyspepsia—Topiramate—migraine	2.55e-05	0.000301	CcSEcCtD
Betaxolol—Hypersensitivity—Gabapentin—migraine	2.54e-05	0.000299	CcSEcCtD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	2.53e-05	0.00136	CbGpPWpGaD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	2.53e-05	0.00136	CbGpPWpGaD
Betaxolol—Diarrhoea—Timolol—migraine	2.53e-05	0.000298	CcSEcCtD
Betaxolol—Decreased appetite—Topiramate—migraine	2.52e-05	0.000297	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Topiramate—migraine	2.5e-05	0.000295	CcSEcCtD
Betaxolol—Fatigue—Topiramate—migraine	2.5e-05	0.000294	CcSEcCtD
Betaxolol—Pain—Topiramate—migraine	2.48e-05	0.000292	CcSEcCtD
Betaxolol—Constipation—Topiramate—migraine	2.48e-05	0.000292	CcSEcCtD
Betaxolol—Asthenia—Gabapentin—migraine	2.47e-05	0.000291	CcSEcCtD
Betaxolol—Nausea—Valproic Acid—migraine	2.47e-05	0.000291	CcSEcCtD
Betaxolol—Dizziness—Timolol—migraine	2.44e-05	0.000288	CcSEcCtD
Betaxolol—Pruritus—Gabapentin—migraine	2.43e-05	0.000287	CcSEcCtD
Betaxolol—Feeling abnormal—Topiramate—migraine	2.39e-05	0.000281	CcSEcCtD
Betaxolol—Diarrhoea—Gabapentin—migraine	2.35e-05	0.000278	CcSEcCtD
Betaxolol—Vomiting—Timolol—migraine	2.35e-05	0.000277	CcSEcCtD
Betaxolol—ADRB1—GPCR ligand binding—HTR2A—migraine	2.33e-05	0.00125	CbGpPWpGaD
Betaxolol—Rash—Timolol—migraine	2.33e-05	0.000275	CcSEcCtD
Betaxolol—Dermatitis—Timolol—migraine	2.33e-05	0.000275	CcSEcCtD
Betaxolol—Headache—Timolol—migraine	2.32e-05	0.000273	CcSEcCtD
Betaxolol—ADRB1—GPCR downstream signaling—HTR1B—migraine	2.31e-05	0.00124	CbGpPWpGaD
Betaxolol—Urticaria—Topiramate—migraine	2.3e-05	0.000271	CcSEcCtD
Betaxolol—Body temperature increased—Topiramate—migraine	2.29e-05	0.00027	CcSEcCtD
Betaxolol—ADRB2—GPCR ligand binding—HTR2A—migraine	2.28e-05	0.00122	CbGpPWpGaD
Betaxolol—Dizziness—Gabapentin—migraine	2.28e-05	0.000268	CcSEcCtD
Betaxolol—ADRB2—GPCR downstream signaling—HTR1B—migraine	2.26e-05	0.00121	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—HTR1A—migraine	2.22e-05	0.00119	CbGpPWpGaD
Betaxolol—Nausea—Timolol—migraine	2.2e-05	0.000259	CcSEcCtD
Betaxolol—ADRB1—GPCR downstream signaling—NPS—migraine	2.19e-05	0.00117	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—TAC1—migraine	2.19e-05	0.00117	CbGpPWpGaD
Betaxolol—Vomiting—Gabapentin—migraine	2.19e-05	0.000258	CcSEcCtD
Betaxolol—ADRB2—GPCR downstream signaling—HTR1A—migraine	2.18e-05	0.00116	CbGpPWpGaD
Betaxolol—Rash—Gabapentin—migraine	2.17e-05	0.000256	CcSEcCtD
Betaxolol—Dermatitis—Gabapentin—migraine	2.17e-05	0.000256	CcSEcCtD
Betaxolol—Headache—Gabapentin—migraine	2.16e-05	0.000254	CcSEcCtD
Betaxolol—ADRB1—GPCR downstream signaling—HTR2C—migraine	2.15e-05	0.00115	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—NPS—migraine	2.14e-05	0.00115	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—TAC1—migraine	2.14e-05	0.00115	CbGpPWpGaD
Betaxolol—Hypersensitivity—Topiramate—migraine	2.13e-05	0.000252	CcSEcCtD
Betaxolol—ADRB2—GPCR downstream signaling—HTR2C—migraine	2.1e-05	0.00112	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HTR1B—migraine	2.1e-05	0.00112	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—EDNRA—migraine	2.09e-05	0.00112	CbGpPWpGaD
Betaxolol—Asthenia—Topiramate—migraine	2.08e-05	0.000245	CcSEcCtD
Betaxolol—ADRB2—Signaling by GPCR—HTR1B—migraine	2.05e-05	0.0011	CbGpPWpGaD
Betaxolol—Pruritus—Topiramate—migraine	2.05e-05	0.000242	CcSEcCtD
Betaxolol—ADRB1—Signaling Pathways—HTR1D—migraine	2.05e-05	0.00109	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—EDNRA—migraine	2.04e-05	0.00109	CbGpPWpGaD
Betaxolol—Nausea—Gabapentin—migraine	2.04e-05	0.000241	CcSEcCtD
Betaxolol—ADRB1—Signaling by GPCR—HTR1A—migraine	2.02e-05	0.00108	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—CALCA—migraine	2.01e-05	0.00108	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR1D—migraine	2e-05	0.00107	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—NPS—migraine	1.99e-05	0.00106	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—TAC1—migraine	1.99e-05	0.00106	CbGpPWpGaD
Betaxolol—Diarrhoea—Topiramate—migraine	1.98e-05	0.000234	CcSEcCtD
Betaxolol—ADRB2—Signaling by GPCR—HTR1A—migraine	1.98e-05	0.00106	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—CALCA—migraine	1.97e-05	0.00105	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HTR2C—migraine	1.95e-05	0.00104	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—TAC1—migraine	1.95e-05	0.00104	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—NPS—migraine	1.95e-05	0.00104	CbGpPWpGaD
Betaxolol—Dizziness—Topiramate—migraine	1.91e-05	0.000226	CcSEcCtD
Betaxolol—ADRB2—Signaling by GPCR—HTR2C—migraine	1.91e-05	0.00102	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR2B—migraine	1.9e-05	0.00102	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—EDNRA—migraine	1.9e-05	0.00102	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—HTR7—migraine	1.88e-05	0.00101	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR2B—migraine	1.86e-05	0.000996	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—EDNRA—migraine	1.86e-05	0.000993	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—HTR7—migraine	1.84e-05	0.000985	CbGpPWpGaD
Betaxolol—Vomiting—Topiramate—migraine	1.84e-05	0.000217	CcSEcCtD
Betaxolol—ADRB1—Signaling by GPCR—CALCA—migraine	1.83e-05	0.000978	CbGpPWpGaD
Betaxolol—Rash—Topiramate—migraine	1.83e-05	0.000215	CcSEcCtD
Betaxolol—Dermatitis—Topiramate—migraine	1.82e-05	0.000215	CcSEcCtD
Betaxolol—Headache—Topiramate—migraine	1.81e-05	0.000214	CcSEcCtD
Betaxolol—ADRB2—Signaling by GPCR—CALCA—migraine	1.79e-05	0.000956	CbGpPWpGaD
Betaxolol—Nausea—Topiramate—migraine	1.72e-05	0.000203	CcSEcCtD
Betaxolol—ADRB1—Signaling by GPCR—HTR7—migraine	1.71e-05	0.000914	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LRP1—migraine	1.67e-05	0.000896	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HTR7—migraine	1.67e-05	0.000894	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LRP1—migraine	1.64e-05	0.000877	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—HTR2A—migraine	1.32e-05	0.000705	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—HTR2A—migraine	1.29e-05	0.00069	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NOTCH4—migraine	1.29e-05	0.000688	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NOTCH4—migraine	1.26e-05	0.000673	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CACNA1A—migraine	1.25e-05	0.000669	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR1B—migraine	1.24e-05	0.000663	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR1B—migraine	1.21e-05	0.000649	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HTR2A—migraine	1.2e-05	0.00064	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR1A—migraine	1.19e-05	0.000639	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TAC1—migraine	1.18e-05	0.000629	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NPS—migraine	1.18e-05	0.000629	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PGR—migraine	1.18e-05	0.000629	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HTR2A—migraine	1.17e-05	0.000626	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR1A—migraine	1.17e-05	0.000625	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR2C—migraine	1.15e-05	0.000617	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NPS—migraine	1.15e-05	0.000615	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PGR—migraine	1.15e-05	0.000615	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TAC1—migraine	1.15e-05	0.000615	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR2C—migraine	1.13e-05	0.000603	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EDNRA—migraine	1.12e-05	0.0006	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EDNRA—migraine	1.1e-05	0.000587	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NOTCH3—migraine	1.09e-05	0.000585	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CALCA—migraine	1.08e-05	0.000577	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NOTCH3—migraine	1.07e-05	0.000572	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CACNA1A—migraine	1.06e-05	0.000567	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CALCA—migraine	1.06e-05	0.000565	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR7—migraine	1.01e-05	0.00054	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR7—migraine	9.88e-06	0.000528	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TGFBR2—migraine	8.69e-06	0.000465	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TGFBR2—migraine	8.5e-06	0.000455	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR2A—migraine	7.07e-06	0.000378	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR2A—migraine	6.92e-06	0.00037	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ESR1—migraine	6.28e-06	0.000336	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ESR1—migraine	6.14e-06	0.000328	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MTHFR—migraine	4.14e-06	0.000221	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MTHFR—migraine	3.5e-06	0.000188	CbGpPWpGaD
